Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: REGENERON PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2017-09-21 to 2026-06-30
Current total value of award: $284843230
Description: THE PURPOSE OF THIS MODIFICATION IS TO: (1) EXTEND THE PERIOD OF PERFORMANCE